Antiplatelet agents and extracorporeal circulation

Addonizio V.P. , Macarak E.J. , Niewiaroswski S. , Colman R.W. , Edmunds L.H. : Preservation of platelets during extracorporeal circulation with prostaglandin E. Trans. Am. Soc. Artif. Intern. Organs 23, 639, 1977.

Baier R.E. : The organization of blood components near interfaces. Ann. N.Y. Acad. Sci. 283, 17, 1977.

Bischel M.O. , Scoles B.G. , Mohler J.G. : Evidence for pulmonary microembolisation during haemodialysis. Chest. 67, 335, 1975.

Brown R.S. , Niewiarowski S. , Stewart G.J. , Millman M. : A double-isotope study on incorporation of platelets and red cells into fibrin. J. Lab. Clin. 90, 130, 1977.

Dawson A. , Lawinski C. , Parson V. , Weston M.J. : Effects of sulphinpyrazone and aspirin on gastrointestinal blood loss in man. Research 12, 947, 1978.

Gimson A.C.S. , Langley P.G. , Hughes R.D. , Canalese J. , Mellon P.J. , Williams R. , Woods H.F. , Weston M.J. : The use of prostacyclin to prevent platelet aggregation during charcoal haemoperfusion in fulminant hepatic failure. Lancet 1980 (in press).

Hampers C.L. , Blaufox M.D. , Merrill J.P. : Anticoagulation rebound after haemodialysis. N. Eng. J. Med. 275, 776, 1966.

Harter H.R. , Burch J.W. , Majerus P.W. , Stanford N. , Delmez J.A. , Anderson C.B. , Weerts C.A. : Prevention of thrombosis in patients on haemodialysis by low-dose aspirin. N. Eng. J. Med. 301, 577, 1979.

Kaegi A. , Pines G.F. , Shimizu A. , Trivedi H. , Hirsh J. , Geat M. : Arteriovenous shunt thrombosis. Prevention by sulphinpyrazone. N. Eng. J. Med. 290, 304, 1974.

Lindner A. , Charra B. , Sherrad D.J. , Scribner B.H. : Accelerated atherosclerosis in prolonged maintenance haemodialysis. N. Eng. J. Med. 290. 697, 1974.

Lindsay R.M. , Prentice C.R.M. , Davidson J.F. , Purton J.A. , NcNicol G.P. ; Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Brit. Med. J. 4, 454. 1972.

Lindsay R.M. , Prentice C.R.M. , Fergusson D. , Burton J.A. , McNicol G.P. : Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 2, 1287, 1972.

Lindsay R.M. , Burton J.A. , Edward N. , Dargie H.J. , Prentice C.R.M. , Kennedy A.C. : Dialyser blood loss. Clin. Neph. 1, 29, 1973.

Longmore D-B. , Bennett G. , Gueirrara D. , Smith M. , Bunting S. , Moncada S. , Reed P. , Read N.G. , Vane J.R. : Prostacyclin: A solution to some problems of extracorporeal circulation. Lancet 1, 1002, 1979.

Marciniak E. , Gocherman J.P. : Heparin-induced decrease in circulating antithrombin III. Lancet 2, 581, 1977.

Marshall J.W. , Ahearn D.J. , Nothum R.J. , Esterly J. , Nolph K.D. , Maher J.F. : Adherence of blood components to dialyser membranes: Morphological studies. Nephron 12, 157, 1974.

Mohring K. , Simm H. , Schuler H.W. , Horsch R. , Kruger M. , Asbach H.W. : Comparative evaluation of iatrogenic sources of blood loss during maintenance dialysis. Proc. Eur. Dial. Transplant Assoc. 13, 233, 1977.

Moncada S. , Higgs E.A. , Vane J.R. : Human arterial and venous tissues generate prostacyclin (prostanglandin X) a potent inhibitor of platelet aggregation. Lancet 1, 18, 1977.

Nath N. , Lowery C.T. , Niewiarowski S. : Antigenic and antiheparin properties of human platelet factor 4. Blood 45, 537, 1975.

OGrady J. : Personal communication. 1979. Proceedings of Symposium held at Lyndhurst 1979.

Richardson P.D. , Galletti P.M. , Born G.V. : Regional administration of drugs to control thrombosis in artificial organs. Trans. Am. Soc. Artif. Intern. Organs 22, 22, 1976.

Thomson C. , Forbes CD. , Prentice C.R.M. : The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin. Sci. Mol. Med. 45, 485, 1973.

Turney J.H. , Woods H.F. , Weston M.J. : Regular haemodialysis therapy includes a prothrombotic state. Thromb. Haemostasis 42, 67, 1979.

Turney J.H. , Woods H.F. , Weston M.J. : Use of prostacyclin in extracorporeal circuits in «Haemostasis, Prostaglandins and Renal Diseases» ed. Remuzzi G. , Mecca G. , de Gaetano G. Raven Press New York, (In press) 1980.

Uziel L. : in «New Aspects of Anticoagulant Therapy during Extracorporeal circulation”. Proceedings of Symposium held at Lyndhurst 1979, Personal communication.

Weston M.J. , Hanid A. , Rubin M.H. , Langley P.G. , Mellon P.J. , Williams R. : Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs. Europ. J. Clin. Invest. 7, 401, 1977.

Weston M.J. , Langley P.G. , Rubin M.H. , Hanid A. , Mellon P.J. , Williams R. : Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion. Gut 18, 897, 1977.

Weston M.J. , Woods H.F. , Bunting S. : Use of prostacyclin during charcoal haemoperfusion. Proceedings of XVIth Congress of European Dialysis and Transplant Association. Pitman Medical Publishing co. 1979. (in press)

Woods H.F. , Ash G. , Weston M.J. , Bunting S. , Moncada S. , Vane J.R. : Prostacyclin can replace heparin in haemodialysis in dogs. Lancet 2, 1075, 1978.

Woods H.F. , Dawson A. , Ash G. , Weston M.J. : Heparin-induced decrease in circulating antithrombin III. Lancet 1, 209, 1978.

Woods H.F. , Ash G. , Parson V. , Weston M.J. : Reduction of dialyser fibrin deposition with sulphinpyrazone. Clin. Neph. 12, 122, 1979.